14 results
PRE 14A
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Preliminary proxy
4:03pm
the consultant’s reasonable fees and other retention terms. Under the charter, the Compensation Committee may select, or receive advice from, a compensation … consult their own tax advisors as to the specific tax consequences of the Reverse Stock Split them, including record retention and tax-reporting
10-K/A
2022 FY
TSHA
Taysha Gene Therapies Inc
27 Apr 23
Annual report (amended)
4:02pm
stockholders. Vesting of equity awards is generally tied to each officer’s continuous service with us and serves as an additional retention measure. Our
8-K/A
EX-10.2
mr24q6 ux
31 Oct 22
Entry into a Material Definitive Agreement
8:45am
8-K
EX-1.1
gidwww7f2 rthdm9m3
27 Oct 22
Taysha Announces Pricing of Public Offering of Common Stock
5:18pm
DEF 14A
oanwtex51psisjv40
29 Apr 21
Definitive proxy
5:03pm
10-K
65ziyrpp0sz 61
3 Mar 21
Annual report
9:00am
- Prev
- 1
- Next